BMS-265246 [CAS 582315-72-8]
Partner: MedChemexpress LLC
CAS No: | 582315-72-8 |
Applications: | Cancer-Kinase/protease |
MW: | 345.34 |
Formula: | C18H17F2N3O2 |
SMILES: | CC1=CC(F)=C(C(C2=CN=C(NN=C3)C3=C2OCCCC)=O)C(F)=C1 |
Purity: | 98.92 |
Description: | BMS-265246 is a potent and selective cyclin-dependent kinase CDK1 and CDK2 inhibitor, with IC50 values of 6 and 9 nM, respectively. BMS-265246 inhibits CHI3L1 (chitinase 3-like-1) stimulation of ACE2 (angiotensin converting enzyme 2) and SPP (viral spike protein priming proteases). BMS-265246 can be used for ovarian cancer and COVID-19 research[1][2][3]. |
Shipping Conditions: | Ship at ambient |
Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice